|
[1]Sarles H, Sarles JC, Muratore R, et al.Chronic inflammatorysclerosis of the pancreas-an autonomous pancreatic dis-ease?[J].Am J Dig Dis, 1961, 6:688-698.
|
|
[2]Yoshida K, Toki F, Takeuchi T, et al.Chronic pancreatitiscaused by an autoimmune abnormality.Proposal of the con-cept of autoimmune pancreatitis[J].Dig Dis Sci, 1995, 40 (7) :1561-1568.
|
|
[3]Shimosegawa T, Kanno A.Autoimmune pancreatitis in Ja-pan:overview and perspective[J].Gastroenterology, 2009, 44 (6) :503-517.
|
|
[4] Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis[J]. Am Gastroenterol, 2004, 99 (8) : 1605-1616.
|
|
[5]Kim MJ, Oh CR, Lee KT.Clinical characteristics of autoim-mune pancreatitis[J].Korean Gastroenterol, 2010, 56 (5) :276-284.
|
|
[6] Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis[J]. N Engl Med, 2006, 355 (25) : 2670-2676.
|
|
[7] Pickartz T , Mayerle J, Lerch MM. Autoimmune pancreatitis[J]. Nat Clin Pract Gastroenterol Hepatol, 2007, 4 (6) : 314-323.
|
|
[8] Gardner TB, Levy MJ, Takahashi N, et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians[J]. Am Gastroenterol, 2009, 104 (7) : 1620-1623.
|
|
[9]Park DH, Kim MH, Chari ST.Recent advances in autoim-mune pancreatitis[J].Gut, 2009, 58 (12) :1680-1689.
|
|
[10]Ng NK, Bong JJ, Williamson RC.Lymphoplasmacytic scle-rosing pancreatitis and retroperitoneal fibrosis[J].HPBSurg, 2008, 2008:719513.
|
|
[11] Vonlaufen A, Frossard JL. Autoimmune pancreatitis[J]. Rev Med Suisse, 2010, 6 (261) : 1662-1666.
|
|
[12]Kamisawa T, Funata N, Hayashi Y.Lymphoplasmacytic scle-rosing pancreatitis is a pancreatic lesion of IgG4-related sys-temic disease[J].Am Surg Pathol, 2004, 28 (8) :1114.
|
|
[13] Chari ST, Murray JA. Autoimmune pancreatitis, part II: the relapse[J]. Gastroenterology, 2008, 134 (2) : 625-628.
|
|
[14] Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases[J]. Am Surg Pathol, 2003, 27 (8) : 1119-1127.
|
|
[15]Zamboni G, Luttges J, Capelli P, et al.Histopathological fea-tures of diagnostic and clinical relevance in autoimmune pancre-atitis:a study on 53 resection specimens and biopsy specimens[J].Virchows Arch, 2004, 445 (6) :552-563.
|
|
[16] Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for Its diagnosis[J]. AM Gastroenterology, 2009, 104 (9) : 2308-2310.
|
|
[17] Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid therapy for autoimmune pancreatitis[J]. Gut, 2009, 58 (11) : 1504-1507.
|
|
[18] Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroid therapy for autoimmune pancreatitis based on long term outcome[J]. Scand Gastroenterol, 2008, 43 (5) : 609-613.
|
|
[19] Nishino T, Toki F, Oyama H, et al. Long term outcome of autoimmune pancreatitis after oral prednisolone therapy[J]. Intern Med, 2006, 45 (8) : 497-501.
|
|
[20] Wakabayashi T, Kawaura Y, Satomura Y, et al. Long term prognosis of duct narrowing chronic pancreatitis: Strategy for steroid treatment[J]. Pancreas, 2005, 30 (1) : 31-39.
|
|
[21]Church NI, Pereira SP, Deheragoda MG, et al.Autoimmunepancreatitis:clinical and radiological features and objectiveresponse to steroid therapy in a UK series[J].Am Gastroen-terol, 2007, 102 (11) :2417-2425.
|
|
[22] Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis[J]. Gastrointest Endosc, 2007, 66 (6) : 1142-1151.
|
|
[23]Ryu JK, Chung JB, Park SW, et al.Review of 67 patientswith autoimmune pancreatitis in Korea-a multicenter nation-wide study[J].Pancreas, 2008, 37 (4) :377-385.
|
|
[24]Frulloni L, Scattolini C, Falconi M, et al.Autoimmune pan-creatitis:differences between the focal and diffuse forms in87 patients[J].Am Gastroenterol, 2009, 104 (9) :2288-2294.
|
|
[25]Kamisawa T, Okamoto A.Prognosis of autoimmune pancre-atitis[J].Gastroenterol, 2007, 42 (18) :59-62.
|
|
[26]Raina A, Yadav D, Krasinskas AM, et al.Evaluation and man-agement of autoimmune pancreatitis:experience at a large UScenter[J].Am Gastroenterol, 2009, 104 (9) :2295-2306.
|
|
[27]Sandanayake NS, Church NI, Chapman MH, et al.Presen-tation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholan-gitis[J].Clin Gastroenterol Hepatol, 2009, 7 (10) :1089-1096.
|
|
[28] Pannala R, Chari ST. Corticosteroid treatment for autoimmune pancreatitis[J]. Gut, 2009, 58 (11) : 1438-1439.
|
|
[29]Sah RP, Chari ST, Pannala R, et al.Differences in clinical pro-file and relapse rate of type 1 versus type 2 autoimmune pancre-atitis[J].Gastroenterology, 2010, 139 (1) :140-148.
|
DownLoad: